Sitagliptin Phosphate

Preferred Label : Sitagliptin Phosphate;

MeSH definition : A pyrazine-derived DIPEPTIDYL-PEPTIDASE IV INHIBITOR and HYPOGLYCEMIC AGENT that increases the levels of the INCRETIN hormones GLUCAGON-LIKE PEPTIDE-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). It is used in the treatment of TYPE 2 DIABETES.;

MeSH synonym : Phosphate, Sitagliptin; Sitagliptin Phosphate Monohydrate; Monohydrate, Sitagliptin Phosphate; Phosphate Monohydrate, Sitagliptin; Sitagliptin Monophosphate Monohydrate; Monohydrate, Sitagliptin Monophosphate; Monophosphate Monohydrate, Sitagliptin;

MeSH hyponym : MK 0431; januvia; sitagliptin phosphate anhydrous; sitagliptin; 0431, MK; MK0431; MK-0431; Anhydrous, Sitagliptin Phosphate; Phosphate Anhydrous, Sitagliptin; 4-Oxo-4-(3-(trifluoromethyl)-5,6-dihydro(1,2,4)triazolo(4,3-a)pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-amine;

MeSH Related Number : 486460-32-6 (sitagliptin); 494P4635I6; 654671-77-9 (sitagliptin phosphate); QFP0P1DV7Z;

Is substance : O;

UNII : TS63EW8X6F;

Details

Origin ID

D000068900;

UMLS CUI

C1667080;

ATC code(s)
- pioglitazone and sitagliptin [ATC Code]
- sitagliptin [ATC Code]
- sitagliptin and dapagliflozin [ATC Code]
- sitagliptin and ertugliflozin [ATC Code]
- sitagliptin and simvastatin [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Sitagliptin [ICD-11 Extension code]
CISMeF manual mappings
- Sitagliptin Phosphate [NCIt concept]
- Sitagliptin phosphate (substance) [SNOMED CT concept]
Pharmacological action(s)
- dipeptidyl-peptidase iv inhibitors [MeSH Descriptor]
- incretins [MeSH Descriptor]
Record concept(s)
- MK 0431 [MeSH concept]
- januvia [MeSH concept]
- sitagliptin [MeSH concept]
- sitagliptin phosphate [MeSH concept]
- sitagliptin phosphate anhydrous [MeSH concept]
Related MeSH Supplementary Concept(s)
- MK-626 [MeSH Supplementary Concept]
See also
- Linagliptin [MeSH Descriptor]
See also inter- (CISMeF)
- Product containing sitagliptin (medicinal product) [SNOMED CT concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Sitagliptin Phosphate [NCIt concept]
- Sitagliptin phosphate (substance) [SNOMED CT concept]
Validated automatic mappings to NTBT
- Sitagliptin [NCIt concept]
- Sitagliptin [SMS substance]
- Sitagliptin (substance) [SNOMED CT concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients